CHRISTOPHER KALB: Open Payments
NPI 1952347338 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 32 payments from 8 companies in 2025. Trend: 2023 $1,167 · 2024 $461 · 2025 $788
Food & beverage: $676Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $312 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $110 |
| Otsuka America Pharmaceutical, Inc. | 1 | $103 |
| Vanda Pharmaceuticals Inc. | 4 | $88 |
| Alkermes, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, REXULTI, FANAPT, HETLIOZ, LYBALVI, INVEGA SUSTENNA, COBENFY.
Industry payments across OH — which companies pay providers there.
